Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.97%
Change (1 year)
Categories
Cerus (CERS) - Net assets
Net assets on the balance sheet as of December 2023 : $53.44 M
According to Cerus's latest financial reports the company has $53.44 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cerus - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $53.44 M | -22.05% |
| 2022-12-31 | $68.56 M | -19.92% |
| 2021-12-31 | $85.61 M | -17.52% |
| 2020-12-31 | $0.10 B | 81.95% |
| 2019-12-31 | $57.05 M | -32.5% |
| 2018-12-31 | $84.51 M | 117.05% |
| 2017-12-31 | $38.94 M | -32.61% |
| 2016-12-31 | $57.78 M | -39.02% |
| 2015-12-31 | $94.76 M | 128.23% |
| 2014-12-31 | $41.52 M | -2.98% |
| 2013-12-31 | $42.79 M | 123.98% |
| 2012-12-31 | $19.1 M | 4.34% |
| 2011-12-31 | $18.31 M | -22.83% |
| 2010-12-31 | $23.73 M | 10.65% |
| 2009-12-31 | $21.44 M | -37.43% |
| 2008-12-31 | $34.27 M | -42.76% |
| 2007-12-31 | $59.88 M | -40.69% |
| 2006-12-31 | $0.10 B | 186.24% |
| 2005-12-31 | $35.27 M | 64.15% |
| 2004-12-31 | $21.48 M | -59.09% |
| 2003-12-31 | $52.52 M | -6.48% |
| 2002-12-31 | $56.16 M | -47.39% |
| 2001-12-31 | $0.10 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $19.53 B | 36,442.92% | 🇺🇸 USA |
 Utah Medical Products UTMD | $0.12 B | 140.09% | 🇺🇸 USA |
 Haemonetics HAE | $0.94 B | 1,665.06% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $2.23 M | -95.82% | 🇺🇸 USA |